🔥 Tuesday 21 April 2026 Tue, 21 Apr 2026

Jindalee Lithium is set to list its McDermitt lithium project on NASDAQ through a US SPAC deal valuing the assets at US$571 million, while securing key US federal approvals and advancing magnesium by-product potential.

Firebrick Pharma secured regulatory approval for Nasodine Nasal Spray in Indonesia and launched Nasodine Throat Spray in Singapore and Fiji, while raising $1.5 million to fuel growth. The company aims to quadruple its product and market footprint within three years.

The Supreme Court of New South Wales has given the green light to the acquisition of National Storage REIT by a Brookfield-GIC consortium, marking a key milestone in a $6.7 billion transaction. Trading in NSR securities will halt as the deal moves toward completion in early May.

Australian Silica Quartz Group (ASQ) is set to acquire Australian Kaolin, adding a 47Mt inferred kaolin resource at White Swan and launching a $750,000 placement to fund development. The deal hinges on shareholder approval and an Independent Expert’s fairness opinion.

The L1 Global Long Short Fund (ASX:GLS) faced a challenging March quarter amid the Iran War-driven oil supply shock but maintains strong performance since inception through active portfolio adjustments and thematic focus on copper, gold, and infrastructure.

VHM Limited has secured A$5 million through a fully underwritten placement priced at A$0.26 per share, funding critical early engineering and procurement ahead of a mid-2026 final investment decision for its Goschen Rare Earth and Mineral Sands Project.

Cooper Metals has swapped its Oorindi Project for the Pyramid Gold Project in North Queensland, a high-grade gold asset in the prolific Drummond Basin. The company plans immediate exploration and a $979,500 capital raise to fund drilling and technical expansion.

Cooper Metals has acquired the Pyramid Gold Project in North Queensland through an asset swap with AIC Mines, exchanging its Oorindi Project and raising nearly $1 million to fund exploration. The deal adds a high-grade, underexplored gold asset to Cooper’s portfolio, with drilling set to ramp up across multiple projects.

Invion Limited is broadening its non-melanoma skin cancer trial to include basal cell carcinoma patients following encouraging safety and efficacy data from squamous cell carcinoma cohorts, targeting the largest skin cancer segment.

Great Southern Mining (ASX:GSN) reported a substantial extension of gold mineralisation at its Golden Boulder discovery in Western Australia, alongside the commencement of deep diamond drilling co-funded by the WA Government. The company also raised A$4.2 million to fuel ongoing exploration.

Sunrise Energy Metals has confirmed strong economics for its Syerston Scandium Project with a US$120 million feasibility study, targeting 60 tonnes per year of scandium oxide and potential expansion to 180 tonnes. The project benefits from US government financing interest and rising global demand amid Chinese export restrictions.

Mineral Resources has priced a US$1.3 billion senior unsecured notes offering to refinance higher-cost debt, reduce annual finance expenses by $48 million, and extend its weighted average debt maturity from 3.1 to 5 years.

Riedel Resources has secured majority control of two large gold projects in Western Australia’s Laverton district, transforming into a multi-jurisdictional explorer with a strong cash position to fund upcoming drilling campaigns.

Riedel Resources has secured a controlling interest in two vast gold projects in Western Australia's Laverton district, transforming it into a multi-jurisdictional gold explorer alongside its Arizona asset. The acquisition comes with a $2.5 million placement to fund aggressive exploration starting mid-2026.

Starpharma has secured FDA alignment on the clinical development plan for its DEP® HER2 radiotherapy candidate, paving the way for a first-in-human phase 1 study in advanced HER2-positive cancers scheduled for H2 2026.

Compumedics maintains robust sales momentum but faces FY26 revenue timing challenges due to MEG installation delays and a cautious Somfit D rollout. The company expects solid year-on-year growth and positions for improved execution in FY27.

Pure Resources has deepened its partnership with Rice University to develop carbon nanotube fibre thermal management technology aimed at AI and defence markets, leveraging its Garnet Hills graphite for a vertically integrated IP pipeline.

Caspin Resources has reported strong high-grade tin assay results from the first 11 holes of its 2026 drilling campaign at the Kelpie Deposit, part of the Bygoo Tin Project in NSW, confirming mineralisation beyond the current resource envelope and supporting potential resource growth.

Buru Energy has enhanced the Rafael Gas Project’s mid-case value by over 45% through new engineering insights, while securing A$5.3 million to advance development. The company delayed appraisal drilling to 2027 to optimise funding and project design, and navigates a leadership change with CEO Thomas Nador stepping down.

AdAlta, Oribiotech, and Cell Therapies have inked a Memorandum of Understanding to deploy Oribiotech’s IRO automated cell therapy manufacturing platform in Australia and Asia Pacific, aiming to slash costs and boost production speed for CAR-T therapies.

CDC Data Centres Australia has clinched its first public investment grade rating from Moody’s, unlocking fresh capital to expand its AI-focused data centre network amid surging demand.

dorsaVi has confirmed that its proprietary RRAM memory technology and neuromorphic IP portfolio work seamlessly together, projecting a tenfold boost in performance for robotics and exoskeleton applications. This breakthrough lays the groundwork for smarter, faster, and more energy-efficient wearable and robotic devices operating at the ultra-edge.

Sunstone Metals has delivered a robust Scoping Study for its Bramaderos Gold-Copper Project in Ecuador, outlining a 23-year mine life, strong production rates, and a post-tax NPV of US$0.9 billion at a conservative gold price. The study highlights low operating costs and substantial exploration upside, setting the stage for a pre-feasibility study and funding pursuits.

MA Financial Group reported a 44% year-on-year jump in assets under management to $14.8 billion in 1Q26, underpinned by strong lending growth and transactional activity despite asset sales and market volatility.